Bidirectional regulation of genistein on the proliferation and differentiation of C2C12 myoblasts

Abstract

1. Genistein is a widely studied phytoestrogen. The effects of genistein on myoblasts were reported long ago, but the conclusions are controversial. In this study, we evaluated the effects of different concentrations of genistein on C2C12 myoblasts.

2. Genistein treatment promoted myoblast proliferation in a dose-dependent manner in the concentration range of 0–2 µM/L, reaching its maximum effect at 2 µM/L. Proliferation then declined, and a concentration higher than 20 µM/L showed significant inhibition. In addition, genistein treatment promoted myoblast differentiation at a dose of 10 µM/L. However, at treatment concentrations higher than 10 µM/L, the effect on myoblast differentiation was rapidly inhibited as the concentration increased.

3. Genistein treatment also down-regulated the expression of miR-222, resulting in increased expression of its target genes, MyoG, MyoD, and ERα and thereby promoting myoblast differentiation.

4. Our results suggest that genistein has a dose-dependent and bidirectional regulation effect on myoblast proliferation and differentiation. We also found that genistein is a miRNA inducer, and it specifically affects the expression of miR-222 to regulate myoblast differentiation.

Keywords:

• Apoptosis
• differentiation
• C2C12 myoblasts
• genistein
• miR-222
• proliferation

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The study was supported by the Sichuan Sci & Tech Support Program [No. 16ZC2838; No. 16ZB0038; No. 2016NZ0089], the Chinese National Sci & Tech Support Program [No. 2015BAD03B01-11], and the earmarked fund for China Agriculture Research System [No. CARS-36-05B].